Pantoprazol Sun Pharma (Pantoprazole)

Pantoprazole blocks the H+/K+‑ATPase enzyme, commonly called the gastric proton pump, on the surface of stomach parietal cells. By forming a covalent bond with the pump, it prevents the final step of acid secretion, leading to a sustained increase in gastric pH and lower acidity.

The prescribed dose of Pantoprazol Sun Pharma is determined by the treating clinician based on the specific indication, patient characteristics and treatment duration. Dosage regimens are individualized and should follow local prescribing guidelines.

Pantoprazole is classified as pregnancy category B in many regions, indicating no evidence of risk in animal studies but limited human data. It is generally considered acceptable when clearly needed, but clinicians should weigh benefits against potential risks. Use while breastfeeding is usually permissible, though monitoring the infant is advised.

To place an order, submit an enquiry on the Pantoprazol Sun Pharma product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Pantoprazol Sun Pharma shares the same class mechanism as other PPIs such as omeprazole and esomeprazole, offering potent acid suppression. Compared with some alternatives, pantoprazole has a lower potential for drug‑drug interactions mediated by CYP2C19, making it a preferred choice when patients are on multiple medications.

Store Pantoprazol Sun Pharma tablets below 25 °C in the original container, protecting them from moisture, heat and direct sunlight. Maintaining these conditions helps preserve potency throughout the product’s shelf life.

Pantoprazol Sun Pharma is taken orally, usually as a whole tablet with a glass of water. It is commonly recommended to take the dose before a meal, preferably in the morning, unless the prescriber advises otherwise.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels, acute interstitial nephritis, and increased risk of bone fractures with long‑term use. Patients should seek medical attention if they experience any concerning symptoms.

Pantoprazol Sun Pharma is contraindicated in individuals with known hypersensitivity to pantoprazole or any other component of the formulation. Caution is also advised for patients with severe liver disease, those requiring certain antiplatelet drugs like clopidogrel, and anyone with a history of allergic reactions to proton pump inhibitors.